Building a Bridge Between the Mechanism of EBV Reactivation and the Treatment of EBV‐Associated Cancers
Journal of Medical Virology · 2025-02 · 97 (2)
DOI: 10.1002/jmv.70192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 27.01.2025. Verfasst von Jialin Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Virus Activation, Epstein-Barr Virus Infections, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 136 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Education Department of Hunan Province., Education Department of Hunan Province.
Abstract (Originalsprache)
Epstein‐Barr virus (EBV) infection is closely associated with the development of various tumors such as lymphomas and epithelial cancers. EBV has a discrete life cycle with latency and lytic phases. In recent years, significant progress has been made in the understanding of the mechanism underlying the transition of EBV from latency to lytic replication. Multiple new lytic activation factors have been emerged and promoted our understanding of this field. In addition, we have comprehensively presented the existing therapeutic strategies and their relationship to the mechanism underlying the transition of EBV from latency to lytic replication in this review, such as lytic induction therapy and drugs to prevent EBV from entering the lytic phase fully utilize the EBV reactivation mechanisms. This year marks the 60th anniversary of the discovery of EBV, and building a bridge between the mechanism of EBV reactivation and the treatment may help us to design new approaches for treating EBV‐associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
- Cancer Research Institute, School of Basic Medicine Sciences, Xiangya School of Medicine, Central South University, Changsha, China.
- Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Nonresolving Inflammation and Cancer, and Hunan Key Laboratory of…
- Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Jian Ma
Förderung
- National Natural Science Foundation of China
- Education Department of Hunan Province.
- Education Department of Hunan Province
Zitieren
APA
Jiang, J., Zhu, X., Li, S., Yan, Q., & Ma, J. (2025). Building a Bridge Between the Mechanism of EBV Reactivation and the Treatment of EBV‐Associated Cancers. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70192
Vancouver
Jiang J, Zhu X, Li S, Yan Q, Ma J. Building a Bridge Between the Mechanism of EBV Reactivation and the Treatment of EBV‐Associated Cancers. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70192
BibTeX
@article{Jiang2025,
author = {Jiang, Jialin and Zhu, Xinlei and Li, Shukun and Yan, Qun and Ma, Jian},
title = {Building a Bridge Between the Mechanism of EBV Reactivation and the Treatment of EBV‐Associated Cancers},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {2},
doi = {10.1002/jmv.70192}
}
EUVIMED